My Newsfeed

logo
The Baseline
05 Dec 2025
Five Interesting Stocks Today - December 5, 2025
By Trendlyne Analysis

1. BLS International:

Thistravel services firm rose 3.6% last week after IDBI Capitalinitiated coverage with a ‘Buy’ rating and a target price of Rs 445. The brokerage noted that BLS International benefits from steady and diversified revenue streams, and strong growth in its core visa and digital services business.

IDBI is positive about BLS’ shift to higher-margin digital services, which are expanding faster than the legacy business. Earnings visibility has improved with recent contract wins. These include the Aadhaar Seva Kendra project worth ~Rs 2,000 crore and a three-year visa services contract in China. It expects profits to grow at a 26% CAGR through FY27, driven by digital identity and e-governance platforms that offer recurring revenue.

InQ2FY26, BLS’ revenue rose 49% YoY to Rs 737 crore, thanks to higher visa applications and the full-quarter contribution from recently acquired businesses. The newly added businesses, iDATA, Citizenship Invest, and Aadifidelis, contributed more than Rs 285 crore to revenue. They also expanded BLS’ footprint into 15 new visa markets and strengthened its presence in high-margin citizenship and residency services. Profit surged 27.4% to Rs 186 crore, supported by an improved operating leverage. 

Joint MD Shikhar Aggarwalsaid, “The Aadhaar project is expected to generate around Rs 350 crore annually once fully ramped up”. Aadifidelis, which provides loan processing and distribution services, currently has lower margins and has shifted the revenue mix toward higher revenue but lower EBITDA. However, the introduction of value-added services such as faster loan processing, credit-profiling support, and digital onboarding is expected to boost profitability.

CFO Amit Sudhakar noted that EBITDA margins have stabilized at around 29% and expects the revenue mix to gradually shift toward a 70-30 split between visa and digital services. He added that the company plans to actively pursue acquisitions over the next few years. The focus will be on businesses valued on EBITDA multiples that can deliver strong returns and complement existing operations.

2. Lemon Tree Hotels:

Thishotel company rose 5.7% in two trading sessions afterannouncing two new hotels on November 27. Lemon Tree is adding a hotel at Surat Airport and a Keys Prima property in Haridwar.

This expansion targets key business and travel hubs. “With these signings, we strengthen our presence in Gujarat and Uttarakhand, which attract a mix of business, spiritual, and leisure travellers,”said Vilas Pawar, CEO of Managed & Franchise Business. The move expands its footprint to 29 hotels in Gujarat (10 operating, 19 upcoming) and 18 in Uttarakhand (nine operating, nine in development).

Q2FY26 financials showed strong momentum. Higher room rates and occupancy hitting 70% fueled a 16.8% YoY profit jump and 7.7% revenue growth. The company also signed 15 new hotels, adding 1,138 rooms to a pipeline now at 121 hotels and 9,118 rooms. Management is targeting an ambitious leap to 35,000–40,000 total rooms over the next three years, nearly double its current 20,000.

Lemon Tree is undertaking its largest-ever renovation, upgrading 4,600 rooms. The investment is already paying off, with refurbished hotels boosting revenue. So far, 3,000 rooms have been completed for Rs 300 crore, with the remaining 1,600 scheduled for the next 15–18 months. Chairman Patanjali Keswanisees a swift return: “Our principle is that any investment we make like this, we want a payback in 2 years. We spent Rs 300 crore; we want a Rs 150 crore increase in EBITDA per year.”

IDBI Capitalmaintained its ‘Buy’ rating and set a price target of Rs 200. The firm is bullish on Lemon Tree’s strong Q2 results, development pipeline and profitable renovations. It forecasts improved margins and consistent earnings growth as upgrades are completed.

3. JSW Steel:

This iron & steel products company’s stock fell 1.6% on December 3 after Nuvama Wealth, Citigroup, and CLSA indicated JSW Steel’s joint venture deal with Japan’s JFE Steel Corp (JFE) for a 50% stake in Bhushan Power and Steel (BPSL) is overvalued. They note that BPSL’s enterprise value (EV) of Rs 53,100 crore implies an EV-to-EBITDA multiple of over 10 times, higher than their estimates. Nuvama and ICICI Securities also estimate JSW will take an 11% EBITDA hit from the reduced contribution from BPSL.

However, other brokerages, including Jefferies, JP Morgan, Morgan Stanley and Motilal Oswal, are positive on the JV deal, citing a significant reduction in JSW’s debt, which will improve its balance sheet for future expansion. 

Motilal Oswal maintained its ‘Buy’ rating on JSW, with a target price of Rs 1,350, a 16.2% upside. The brokerage believes the JV will cut JSW’s consolidated debt by Rs 35,000 crore, including BPSL’s Rs 5,000 crore debt, reducing its debt-to-EBITDA to 1.7 by FY27 from 3 in Q2FY26. It expects the company to deliver a revenue CAGR of 10.9% over FY26-28.

As part of the JV deal, BPSL will transfer to JSW Sambalpur Steel via a slump sale for Rs 24,480 crore. Subsequently, JFE Steel Corp will acquire a 50% stake in BPSL. JSW acquired BPSL in 2021 through an insolvency process. Since then, JSW has boosted BPSL's capacity from 2.8 million tonnes per annum (MTPA) to 4.5 MTPA, making it profitable.

The JV combines JSW Steel’s execution strength with JFE’s technological expertise to produce high-value steel. It allows JSW to monetise the value created from BPSL’s turnaround and reduce debt. The deal also helps JSW focus on its long-term plan to achieve 50 MTPA steel capacity in India by FY31.

In Q2FY26, JSW’s revenue grew 14.1% YoY, beating Forecaster estimates by 2.3%. Capacity ramp-ups drove this growth. Net profit surged 3.7 times, supported by lower coking coal and mining premium expenses. The company also plans to expand its India steel capacity to 42.5 MTPA by FY29 with a Rs 69,000 crore capex.

Jayant Acharya, Joint MD & CEO of JSW Steel, noted, “The ongoing expansions will take our India capacity from the current 34.2 million to 41.9 million by September '27. We have also approved setting up an electric arc furnace project in Kadapa, Andhra Pradesh, by the end of FY29, taking our India capacity to 42.9 MTPA.”

4. TVS Motor Company:

This 2/3 wheeler maker rose 3.7% on December 1 after its total vehicle sales grew 30% YoY to 5.2 lakh units in November. This was driven by a 27% increase in two-wheeler sales and a 58% growth in its international business. The strong performance was helped by a recovery in rural demand, more affordable prices after GST cuts, and lower interest rates.

TVS had reported a strong set of numbers during the September quarter. Profit increased 42% YoY to Rs 795.5 crore, driven by higher sales volumes. Cost control measures and a premium product mix helped the EBITDA margin improve by 100 bps YoY to 12.7%.

Revenue increased 24%, driven by strong sales momentum across all its segments. A 23% rise in total two- and three-wheeler sales in Q2 marked its highest-ever quarterly sales volume. EV sales were up 7%, though the company noted ongoing challenges with the availability of rare-earth magnets. The company expects its EV sales to improve from the third quarter with the rollout of its new Orbiter EV and as supply chain problems gradually ease.

Commenting on the demand outlook, CEO K N Radhakrishnan said, “We are expecting good momentum in Q3 with the GST benefit, supported by rate cuts and improving rural sentiment.” He anticipates commodity cost pressures to be softer in Q3 compared to Q2, while pricing discipline, favourable product mix and material cost-saving initiatives are likely to support margin expansion.

Nuvama maintains a 'Buy' rating on TVS Motor with a target price of Rs 4,100. The brokerage expects double-digit growth in both domestic and export markets, with the company's market share increasing to 19% by FY28. It also notes the company’s planned premium launches under its high-end Norton brand starting from FY26.

5. Petronet LNG:

The stock of this oil marketing & distribution company rose 4.5% on December 4 after it announced a major 15-year contract with ONGC for Ethane Unloading, Storage, and Handling (USH) services. This binding deal is expected to generate a gross revenue of about Rs 5,000 crore over its duration, with services beginning in 2028. Under the agreement, ONGC will reserve 600 kilo tonnes per annum (KTPA) of capacity at the company’s Ethane storage facilities in Dahej, Gujarat.

The company's underlying momentum remains strong despite a muted second quarter. Its net profit slipped by 4.9% YoY to Rs 805.8 crore, primarily due to foreign exchange losses and higher operating costs linked to leasing gas carriers. The profit missed Trendlyne’s Forecaster estimate by 8.1%. Its stock features in a screener of companies where mutual funds have been increasing shareholding over the past month.

Defying the overall weak quarter, the company’s Kochi terminal logged its highest-ever utilization rate, powered by a significant cargo import from Bharat Petroleum for regasification. Management expects this utilization rate to improve significantly over the long term, betting on global LNG prices to eventually soften. Furthermore, the final leg of the natural gas pipeline connecting Kochi to Bangalore is a crucial piece of infrastructure expected to be completed by the end of FY26.

CFO Saurav Mitra confirmed the full-year capital expenditure target remains Rs 5,000 crore. He noted that the improved utilization at the Kochi terminal, driven by BPCL imports, is expected to be a continuing trend. Looking at new projects, the company is constructing extensive Ethane storage facilities at Dahej, along with a unique third jetty that will be capable of handling not only LNG but also Ethane and Propane.

Motilal Oswal maintained a ‘Buy’ rating on the stock with a target price of Rs 390. However, the brokerage noted that the 5 million metric tonnes per annum (mmtpa) capacity expansion at the Dahej terminal is now expected to be completed by the end of March 2026, marking a three-month delay. Due to this delay and recent soft service volumes, the brokerage has slightly reduced its near-term volume forecast for the Dahej terminal to 16.9 mmtpa from 17.1mmtpa given earlier.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

Market closes higher as RBI cuts repo rate by 25 bps
By Trendlyne Analysis

Nifty 50 closed at 26,186.45 (152.7, 0.6%), BSE Sensex closed at 85,712.37 (447.1, 0.5%) while the broader Nifty 500 closed at 23,835.25 (94.2, 0.4%). Market breadth is in the red. Of the 2,581 stocks traded today, 934 were gainers and 1,604 were losers.

Indian indices closed higher after extending gains throughout the day. The Indian volatility index, Nifty VIX, fell 4.7% and closed at 10.3 points. RBI’s Monetary Policy Committee (MPC) cut the policy repo rate by 25 bps to 5.25% and maintained its policy stance at ‘Neutral.’ It also raised its FY26 GDP growth forecast to 7.3%, up from 6.8%.

Nifty Smallcap 100 closed lower, while Nifty Midcap 100 closed in the green. Nifty PSU Bank and Nifty Financial Services were among the top index gainers today. According to Trendlyne’s sector dashboard, Diversified emerged as the best-performing sector of the day, with a rise of 1.3%.

European indices are trading in the green, except for Switzerland’s SMI and Portugal’s PSI indices. Major Asian indices closed mixed. US index futures are trading mixed, indicating a cautious start to the session, as investors await the release of the PCE inflation print later today. Netflix is reportedly in talks to acquire key assets of Warner Bros Discovery, a move that could significantly boost its position in Hollywood.

  • Relative strength index (RSI) indicates that stocks like Bajaj Housing Finance, Kaynes Technology, Ola Electric Mobility, and Deepak Nitrite are in the oversold zone.

  • Motilal Oswal retains its 'Buy' call on Aurobindo Pharma, with a target price of Rs 1,430 per share. This indicates a potential upside of 17.9%. The brokerage remains positive on the stock, driven by a diverse portfolio, capacity scale-up, increasing biosimilar approvals, acquisitions, and biosimilar commercialisation across Europe and the US. It expects the firm to deliver a net profit CAGR of 21% over FY26-28.

  • Ganesh Housing's board of directors approves the merger of its subsidiary, Ganesh Properties, with itself.

  • Fineotex Chemical surges as its subsidiary acquires 53.3% stake in CrudeChem Technology, FrackMex Equipment and Services, Oil Pro Advantage and Lonestar Technoboost for $11.2 million (around Rs 101 crore) to expand its business in the speciality chemical sector.

  • Antique Stock Broking maintains a 'Buy' rating on Zen Technologies with a target price of Rs 1,744. The brokerage says a pickup in orders could help Zen Tech close FY26 on a stronger footing. After an expected FY26 dip, it forecasts profit growth of 97.6% in FY27 and 29.8% in FY28. Antique believes the company is well-placed for two orders worth Rs 880–1,000 crore, which could substantially boost its FY26 order book and improve FY27 earnings visibility.

  • Windsor Machines is rising as its board of directors approves the merger of its subsidiary, Global CNC, with itself.

  • Waaree Energies' wholly-owned subsidiary, Waaree Solar Americas, receives an order from a renowned customer to supply 288 MW solar modules.

  • eClerx Services' board of directors approves a buyback of 6.7 lakh shares worth Rs 300 crore for Rs 4,500 per share, sets December 17 as the record date.

  • Adani Group and Hindalco Industries reportedly consider investments in Peru’s copper sector, either through joint ventures or stakes in existing mines. With demand set to rise and supply risks ahead, the government is promoting overseas mining investments to secure copper supplies. India’s copper demand could reach around 3 million tonnes by 2030 and nearly 8.9–9.8 million tonnes by 2047.

  • Railtel Corp of India bags an order worth Rs 63.9 crore from the Central Public Works Department (CPWD) to design and implement the information and communications technology (ICT) network.

  • Cyient's subsidiary, Cyient Semiconductors, secures a contract for the supply and qualification of technology intellectual property (IP) for the Rs 4,500 crore modernisation of the Semi-Conductor Laboratory (SCL) in Mohali.

  • Seamec is rising as it signs a multi-year charter hire agreement worth $43.1 million (about Rs 387 crore) with HAL Offshore to deploy its multi-support Agastya vessel.

  • Mukund Vasudevan, MD of SKF India, sets a 17–19% margin target over the next 3–4 years, with both the industrial and auto segments expected to deliver mid-teen margins. He highlights the company's plans to invest Rs 800–950 crore during this period and anticipates double-digit revenue growth as the investment pays off. Vasudevan adds that about 70% of the capex is planned for the new Pune plant.
  • Brookfield India Real Estate Trust is rising as its board of directors approves a qualified institutional placement (QIP) of shares worth Rs 3,500 crore, at a floor price of Rs 327.3 per share.

  • IndiGo is falling as it reportedly cancels all departures from Delhi until midnight, adding to nationwide disruptions that have hit its network for several days. The airline is also cancelling flights across several major cities, including Bengaluru, Mumbai, Hyderabad and Chennai, as it manages schedule instability caused by crew shortages under the new Flight Duty Time Limitations rules.

  • Geojit BNP Paribas retains its 'Hold' rating on Trent, with a lower target price of Rs 4,640 per share. This indicates a potential upside of 10.7%. The brokerage believes that the company's initiatives on youth-focused brand launches, overseas pilots and deeper penetration in emerging cities along with strong festive demand will drive medium term growth. It expects the firm to deliver a revenue CAGR of 22.5% over FY26-27.

  • RBI’s Monetary Policy Committee raises its GDP growth forecast for the current financial year to 7.3%, up from 6.8%. It also lifts its quarterly projections, expecting 7% growth in Q3 and 6.5% in Q4. Governor Sanjay Malhotra says underlying inflation is softer than the headline print, noting that higher precious metal prices alone are contributing roughly 50 bps to the current reading.

  • Deepak Nitrite is rising as it expands its capacity by setting up a nitric acid plant in Vadodara, at a capex of Rs 515 crore.

  • Lloyds Engineering Works is rising sharply as it enters an agreement with Italy's Virtualabs SRL to jointly develop radar technology for defence and civil applications.

  • Shriram Pistons & Rings surges as it agrees to acquire three Grupo Antolin entities, Antolin Lighting, Grupo Antolin India, and Grupo Antolin Chakan for approximately €159 million (Rs 1,670 crore) to expand its presence in the automotive components industry.

  • RBI’s Monetary Policy Committee (MPC) cuts the policy repo rate by 25 bps to 5.25% and maintains its policy stance at ‘Neutral.’ RBI Governor Sanjay Malhotra says rural demand stays strong, while urban demand is steadily improving. He adds that investment activity remains solid, with private investment picking up amid rising non-food bank credit and high capacity utilisation.
  • Spicejet rises sharply as the management expects to be profitable in the coming quarters after two consecutive quarters of losses. It notes that the sustained growth in aircraft utilisation, stronger capacity deployment and improved cost control will drive this profitability. The management also expects to reduce its Rs 2,381 crore debt by 35%, led by enhanced operating performance.

  • Zen Technologies is rising as it receives orders worth Rs 120 crore from the Ministry of Defence to supply a comprehensive training node (CTN) that includes multiple training simulators and related equipment.

  • Diamond Power Infrastructure surges as it receives an order worth Rs 747.6 crore from Adani Green Energy to supply 33KV high-voltage cables and 3.3KV solar medium-voltage cables for the Khavda and Rajasthan projects.

  • ITC Hotels is rising as British American Tobacco (BAT) reportedly plans to sell a 7-15.3% stake worth Rs 2,948 crore via a block deal.

  • Nifty 50 was trading at 26,050.60 (16.9, 0.1%), BSE Sensex was trading at 85,125.48 (-139.8, -0.2%), while the broader Nifty 500 was trading at 23,745.25 (4.2, 0.0%).

  • Market breadth is in the red. Of the 2,053 stocks traded today, 882 were on the uptick, and 1,111 were down.

Riding High:

Largecap and midcap gainers today include Mahindra & Mahindra Financial Services Ltd. (367.55, 5.9%), Patanjali Foods Ltd. (550.80, 4.2%) and SBI Cards and Payment Services Ltd. (885.15, 3.4%).

Downers:

Largecap and midcap losers today include Hindustan Unilever Ltd. (2,338.60, -5.0%), Waaree Energies Ltd. (2,871.40, -3.8%) and Hitachi Energy India Ltd. (19,365, -3.6%).

Crowd Puller Stocks

17 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Rashtriya Chemicals & Fertilizers Ltd. (141.99, 4.8%), Patanjali Foods Ltd. (550.80, 4.2%) and Himadri Speciality Chemical Ltd. (476.75, 3.1%).

Top high volume losers on BSE were Kaynes Technology India Ltd. (4,353.50, -12.6%), Westlife Foodworld Ltd. (558.55, -3.1%) and Amber Enterprises India Ltd. (6,571, -2.7%).

Zen Technologies Ltd. (1,388.70, 1.0%) was trading at 6.8 times of weekly average. Aditya Birla Real Estate Ltd. (1,755, -1.2%) and SKF India Ltd. (1,878.30, -0.7%) were trading with volumes 6.1 and 5.5 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

5 stocks took off, crossing 52 week highs, while 26 stocks hit their 52 week lows.

Stocks touching their year highs included - Hero MotoCorp Ltd. (6,350.50, 0.2%), Hindustan Copper Ltd. (371.85, 1.7%) and National Aluminium Company Ltd. (273.15, 1.5%).

Stocks making new 52 weeks lows included - BASF India Ltd. (4,059.90, -0.1%) and Bata India Ltd. (966.95, 0.7%).

11 stocks climbed above their 200 day SMA including SBI Cards and Payment Services Ltd. (885.15, 3.4%) and Himadri Speciality Chemical Ltd. (476.75, 3.1%). 8 stocks slipped below their 200 SMA including Hindustan Unilever Ltd. (2,338.60, -5.0%) and Waaree Energies Ltd. (2,871.40, -3.8%).

Market closes higher, supported by gains in IT and telco stocks
By Trendlyne Analysis

Nifty 50 closed at 26,033.75 (47.8, 0.2%), BSE Sensex closed at 85,265.32 (158.5, 0.2%), while the broader Nifty 500 closed at 23,741.10 (24.8, 0.1%). Market breadth is in the red. Of the 2,593 stocks traded today, 1,050 showed gains, and 1,492 showed losses.

Indian indices closed higher after recovering from the losses in the afternoon session. The Indian volatility index, Nifty VIX, declined 3.7% and closed at 10.8 points. Vedanta received approval from the National Company Law Tribunal (NCLT) for its resolution plan to acquire Incab Industries for Rs 545 crore under the corporate insolvency resolution process.

Nifty Midcap 100 closed flat, while Nifty Smallcap 100 closed in the red. Nifty IT and BSE IT Sector were among the top index gainers today. According to Trendlyne’s Sector dashboard, Software & Services emerged as the best-performing sector of the day, with a rise of 1.2%.

Asian indices closed mixed, while European indices are trading higher. US index futures traded higher, indicating a positive start to the trading session. According to ADP National Employment report, US private payrolls unexpectedly fell by 32,000 in November after a revised 47,000 gain in October, reinforcing concerns about a cooling labor market. The weaker data has lifted expectations of a Fed rate cut this month, with CME FedWatch putting the odds of a 25 bps cut in the December 9-10 meeting at nearly 90%.

  • Money flow index (MFI) indicates that stocks like Supreme Industries, Bajaj Housing Finance and Deepak Nitrite are in the oversold zone.

  • Morepen Laboratories receives a Rs 117.9 crore show cause notice from the GST Authority for FY21-24.

  • Brigade Enterprises is rising as it acquires a 4-acre land in Neopolis Phase-3 for Rs 118 crore per acre in an auction held by the Hyderabad Metropolitan Development Authority (HMDA).

  • Lupin is rising as it signs a licensing agreement with US-based biosimilar specialist Valorum Biologics for the commercial launch of Armlupeg. Under the agreement, Lupin will handle manufacturing and supply for an upfront licensing fee along with royalty payments based on net sales, strengthening its US biosimilar revenue stream.

  • BofA Securities expects the Nifty 50 to reach 29,000 next year, implying about 11.5% upside. The brokerage expects largecaps to outperform midcaps and smallcaps in CY26, but still sees selective opportunities in financials, IT, chemicals, jewellery, consumer durables, and hotels. It adds that risks are skewed to the upside due to potential reforms and a reversal in FII outflows, though any downside could lead to sharper corrections in small & midcap stocks.

  • BEML secures an order worth Rs 157 crore from Loram Rail Maintenance India to manufacture switch rail-grinding machines for track maintenance.

  • Northern Arc Capital's Managing Director & CEO, Ashish Mehrotra, estimates its assets under management (AUM) to grow 27-30% in FY26, driven by improvements in the micro, small & medium enterprises (MSME), secured borrowers, and consumer lending segments. He also expects the company to deliver a net interest margin (NIM) of 11-12% over the next two years, backed by growth in fee income and lower credit costs.

  • Hubtown is rising as its board of directors approves raising Rs 500.6 crore by issuing 1.5 crore shares through a preferential issue at an issue price of Rs 341 per share. The company will use Rs 150 crore from the proceeds to pay outstanding loans.

  • Manoj Kumar Dubey, CEO & CMD of IRFC, says the company’s long-standing ties with Japanese banks for external commercial borrowings (ECB) offer a chance to include yen in its borrowing mix. He expects net interest margin (NIM) to expand over the next 25 quarters. Dubey also anticipates surpassing the FY26 sanctions target of Rs 60,000 crore as early as Q3 and reiterates disbursement guidance of over Rs 30,000 crore for the year.

  • Reliance Industries is rising as its subsidiary, Reliance Strategic Business Ventures (RSBVL), acquires a 49% stake in the Oval Invincibles franchise from the England & Wales Cricket Board for GBP 60.3 million (around Rs 723.7 crore). Both the men’s and women’s teams will operate under the new name MI London, effective 2026.

  • Pine Labs' Q2FY26 net profit jumps 24.6% QoQ to Rs 6 crore, helped by lower employee benefits and finance costs. Revenue grows 3% QoQ to Rs 672.9 crore, owing to improvements in the digital infrastructure & transaction, and issuing & acquiring segments. It features in a screener of stocks with declining provisions.

  • Mahindra & Mahindra is rising as its wholly-owned subsidiary, Mahindra Overseas Investment (MOICML), sells a 3.6% stake in CIE Automotive (CIE Spain) for approximately €119 million (around Rs 1,250 crore).

  • Citi maintains a 'Buy' rating on Tata Consumer Products with a lower target price of Rs 1,350. The brokerage expects volume-driven growth in India’s tea category with modest price gains in H2FY26. It notes a strong revival in the ready-to-drink segment and anticipates a gradual improvement in Capital Foods, supported by various initiatives. Citi also expects long-term earnings to benefit from a solid margin recovery.

  • IDBI Capital initiates coverage on BLS International with a 'Buy' rating and a target price of Rs 445 per share. This indicates a potential upside of 32%. The brokerage is positive on the stock, supported by international expansion, cost control, process automation, and the high-margin digital services segment. It expects the firm to deliver a revenue CAGR of 23.5% over FY26-27.

  • The National Company Law Tribunal (NCLT) rejects Goodrich Logistics' plea against Transrail Lighting for non-payment of outstanding dues. The dues relate to two orders of equipment and accessories for the construction of Transrail's 330 KV DC transmission line in Nigeria.

  • TeamLease Services' board of directors appoints Suparna Mitra as the Chief Executive Officer (CEO) and Managing Director (MD), succeeding Ashok Reddy, effective February 2.

  • InterGlobe Aviation (IndiGo) falls after a two-day network disruption that led to roughly 150 cancellations and impacted around 200 flights in total. The disruption coincided with a DGCA-mandated emergency update for Airbus A320 jets and the implementation of new fatigue-management (FDTL) norms, effective from November 1.

  • Pace Digitek's subsidiary, Lineage Power, secures an order worth Rs 99.7 crore from Advait Greenergy for a lithium iron phosphate (LFP) battery energy storage system (BESS) and related equipment.

  • Vedanta is rising as it receives approval from the National Company Law Tribunal (NCLT) for its resolution plan to acquire Incab Industries for Rs 545 crore under the corporate insolvency resolution process.

  • JK Cement expands its clinker capacity by adding 3.3 million tonnes per annum (MTPA) Line-2 at Prayagraj, taking the total capacity to 6.6 MTPA.

  • Fitch Ratings raises India’s FY26 growth forecast to 7.4%, citing strong private consumption and resilient GDP performance despite a global slowdown. It expects FY27 growth to slow to 6.4% as the economy matures, with domestic demand and consumer spending continuing to drive activity.

  • Godawari Power & Ispat rises as it receives approval from the Chhattisgarh Environment Conservation Board (CECB) to operate its 2 million tonnes per annum (MTPA) iron ore pellet plant. This takes the company's total pellet capacity to 4.7 MPTA, up from 2.7 MTPA.

  • Petronet LNG is rising as it signs a 15-year agreement worth Rs 5,000 crore with Oil and Natural Gas Corp (ONGC) to provide unloading, storage, and handling services for 600 KTPA of ethane at its Dahej facility.

  • Eris Lifesciences plans a capex of Rs 380-400 crore over the next three quarters, funded through internal accruals. The company will use this capex to double insulin capacity in Bhopal, set up Unit-3 for general-sterile injectables, and enhance the diabetes & obesity pipeline.

  • Rail Vikas Nigam is rising as it receives an order worth Rs 145.3 crore from Southern Railway. The order includes setting up traction substations, installing power equipment, adding remote monitoring and control systems for the power network, and setting up fault-detection systems on the Jolarpettai–Salem route.

  • Nifty 50 was trading at 25,949.55 (-36.5, -0.1%), BSE Sensex was trading at 85,007.21 (-99.6, -0.1%) while the broader Nifty 500 was trading at 23,693.55 (-22.8, -0.1%).

  • Market breadth is in the red. Of the 2,068 stocks traded today, 834 were gainers and 1,168 were losers.

Riding High:

Largecap and midcap gainers today include Petronet LNG Ltd. (280.95, 4.5%), L&T Technology Services Ltd. (4,685.10, 3.8%) and Coforge Ltd. (1,966.20, 2.8%).

Downers:

Largecap and midcap losers today include Hitachi Energy India Ltd. (20,085, -8.1%), Biocon Ltd. (388.35, -5.3%) and Patanjali Foods Ltd. (528.75, -4.8%).

Crowd Puller Stocks

24 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included India Cements Ltd. (412.15, 9.7%), Hindustan Copper Ltd. (365.75, 7.8%) and Kirloskar Oil Engines Ltd. (1,165.10, 7.4%).

Top high volume losers on BSE were Hitachi Energy India Ltd. (20,085, -8.1%), Biocon Ltd. (388.35, -5.3%) and Ola Electric Mobility Ltd. (36.12, -5.0%).

Godrej Industries Ltd. (1,000.80, -3.5%) was trading at 16.9 times of weekly average. Usha Martin Ltd. (436.15, 2.8%) and J B Chemicals & Pharmaceuticals Ltd. (1,821.70, 3.3%) were trading with volumes 12.0 and 7.3 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

5 stocks overperformed with 52 week highs, while 20 stocks hit their 52 week lows.

Stocks touching their year highs included - Asian Paints Ltd. (2,957.20, 0.1%), Hero MotoCorp Ltd. (6,340, 2.1%) and Hindustan Copper Ltd. (365.75, 7.8%).

Stocks making new 52 weeks lows included - BASF India Ltd. (4,063.50, -0.5%) and Bata India Ltd. (960.30, -1.8%).

10 stocks climbed above their 200 day SMA including Himadri Speciality Chemical Ltd. (462.35, 2.9%) and Astral Ltd. (1,440.70, 2.2%). 13 stocks slipped below their 200 SMA including Wockhardt Ltd. (1,331.90, -5.9%) and Elgi Equipments Ltd. (491.45, -3.0%).

Market closes lower as the rupee hits an all-time low

Nifty 50 closed at 25,986 (-46.2, -0.2%), BSE Sensex closed at 85,106.81 (-31.5, 0.0%) while the broader Nifty 500 closed at 23,716.30 (-106.0, -0.4%). Market breadth is overwhelmingly negative. Of the 2,595 stocks traded today, 798 were in the positive territory and 1,750 were negative.

Indian indices closed lower after falling in the morning session as the Indian rupee dropped to its all-time low of Rs 90.3 against the US dollar. The Indian volatility index, Nifty VIX, fell 0.1% and closed at 11.2 points. India’s Services Purchasing Managers’ Index (PMI) rose to 59.8 in November from 58.9 in October, as growth in new business boosted services output.

Nifty Smallcap 100 and Nifty Midcap 100 closed lower. Nifty PSU Bank and Nifty India Defence were among the top index losers today. According to Trendlyne’s sector dashboard, Fertilizers emerged as the worst-performing sector of the day, with a fall of 1.5%.

Asian indices closed mixed. European indices are trading with varied trends. US index futures are trading higher. Investors are now focused on a possible Federal Reserve rate cut later this month, with CME FedWatch showing an 87% probability of a 25-bps cut at the December 9–10 meeting. Brent crude futures are trading higher as the chances of an immediate peace deal in Ukraine remain low, keeping supply risks elevated.

  • Relative strength index (RSI) indicates that stocks like Deepak Nitrite, Bajaj Housing Finance, Conhance Lifesciences and Bata are in the oversold zone.

  • JSW Steel forms a 50:50 joint venture with Japan's JFE Steel to operate Bhushan Power & Steel's steel business. The company also approves merging Piombino Steel into itself. This simplifies the group structure and gives JSW Steel direct ownership of BPSL’s integrated steel assets.

  • IndiGrid Infrastructure Trust enters a share purchase agreement to acquire a 100% stake in Gadag Transmission from ReNew Transmission Ventures (RTVPL) and KNI India AS (KNI) for Rs 372 crore.

  • Bharat Rasayan's board of directors sets December 12 as the record date for its 1:2 stock split and 1:1 bonus issue.

  • Nuvama upgrades Shoppers Stop to a 'Buy' rating with a target price of Rs 595. The brokerage says the recent correction offers a margin of safety, and the “Shoppers Stop 2.0” turnaround is showing clear progress. It highlights the company's renewed focus on premiumisation, store experience, and loyalty programmes. Nuvama believes this strategy and planned scale-up position the retailer well for long-term growth.

  • Ashok Leyland is rising as BofA Securities reportedly upgrades its target price to Rs 180 per share, while maintaining a 'Buy' rating on the stock. This indicates a potential upside of 11.1%. The brokerage believes that the company's medium and heavy commercial vehicles segment will grow in the mid-single digits, driven by scale-up of the truck rental segment and a strong fleet age.

  • Websol Energy Systems signs a memorandum of understanding (MoU) with Linton to manufacture photovoltaic (PV) ingots and wafers in India. Under the MoU, Websol will procure the ingot and wafer manufacturing equipment and technical expertise from Linton.

  • Gujarat Pipavav Port is rising as it signs a memorandum of understanding (MoU) with NYK India to upgrade its roll-on/roll-off (RoRo) infrastructure at Pipavav port to handle 5 lakh cars annually.

  • CLSA maintains an 'Outperform' rating on Hindalco with a target price of Rs 965. The brokerage says a strong aluminium price outlook eases Novelis-related concerns. It expects expansion plans could double EBITDA over the next five years, with stronger free cash flow (FCF) in the later stages. Management remains upbeat on aluminium prices. CLSA notes that Indonesia's capacity additions may face power constraints, while China approaches its 45 metric tonne (MT) limit.

  • MOIL's manganese ore sales rise 3% YoY to 1.4 lakh metric tonnes in November, while its ore production grows 1% YoY to 1.7 lakh metric tonnes.

  • BEML secures an order worth Rs 414 crore from Bangalore Metro Rail Corp (BMRCL) to supply trainsets for Bangalore Metro Rail Project, phase-II.

  • NBCC (India) secures five orders worth Rs 665.4 crore from various clients. The largest contract comes from the Ghaziabad Development Authority for the redevelopment of Tulsi Niketan. The remaining orders include renovation and construction work for The Institute of Cost Accountants of India, the National Forensic Science University, and The Institute of Company Secretaries of India.

  • Antique Stock Broking initiates coverage on DOMS Industries with a 'Buy' rating and a target price of Rs 3,250. The brokerage believes Doms is well-positioned for faster growth, backed by capacity expansion, wider distribution, and a strong innovation pipeline. It highlights the company’s push into adjacent categories, like bags and toys, as well as acquisitions such as Uniclan and Super Treads. The management remains confident in achieving 18–20% annual growth.

  • Indian Railway Finance Corp is rising as it signs a 5-year loan agreement worth $300 million (~Rs 2,707.9 crore) with Sumitomo Mitsui Banking Corp. The company will use the proceeds from this loan to finance the railway sector and other projects.

  • KPI Green Energy receives an order worth Rs 489.2 crore from Gujarat State Electricity Corp (GSECL) to build a 142 MW (DC) / 110 MW (AC) floating solar project at the Kadana Dam reservoir in Mahisagar, Gujarat.

  • Geojit BNP Paribas retains its 'Buy' call on Va Tech Wabag, with a target price of Rs 1,877 per share. This indicates a potential upside of 34.5%. The brokerage believes that sustained execution of the company's large order book will drive revenue growth. However, it notes that a higher proportion of construction contracts in the recent mix will weigh on margins. It expects the firm's revenue to grow at a CAGR of 17% over FY26-27.

  • India’s services PMI climbs to 59.8 in November from 58.9 in October, driven by strong new business that boosted services output. However, employment growth stays modest, and the overall composite PMI slightly cools to 59.7 due to slower manufacturing growth.

  • Adani Enterprises reportedly plans a $15 billion (~Rs 1.4 lakh crore) capex to increase passenger capacity to 200 million per year by 2030. The company aims to add terminals, taxiways, and a new runway at the Navi Mumbai airport and capacity upgrades at Ahmedabad, Jaipur, Thiruvananthapuram, Lucknow, and Guwahati airports.

  • Sun Pharmaceutical Industries' subsidiary, Sun Pharma Laboratories, approves a capex of Rs 3,000 crore to set up a greenfield formulations facility in Madhya Pradesh.

  • Embassy Office Parks REIT rises to its 5-year high of Rs 440 per share as its board of directors approves acquiring a 100% stake in Eleanor Realty Holdings India at an enterprise value of Rs 852 crore. Eleanor Realty owns and operates a commercial office space, Pinehurst, with a total leasable area of 2.9 lakh sq ft.

  • Commodore A Madhavarao, CMD of Bharat Dynamics, says the company is preparing for rapid expansion, supported by a Rs 36,000 crore FY26 order book, strong export demand, and capacity additions. Bharat Dynamics targets a turnover of Rs 10,000 crore by FY30 and aims for 20–25% annual growth across all divisions, with plans to double revenue over the next 2–3 years.

  • Dr Reddy's Laboratories rises after the Delhi High Court reportedly allows the company to manufacture and export its weight-loss drug, Semaglutide. However, Dr Reddy's will not be allowed to sell the drug in India till the Danish drugmaker, Novo Nordisk's, secondary patent expires in March 2026. This move comes despite Novo Nordisk pursuing a patent infringement case.

  • Mahindra Lifespace secures a redevelopment project in Matunga, Mumbai. The project is expected to generate a gross development value (GDV) of Rs 1,010 crore.

  • Angel One is falling as its average daily turnover (ADTO) drops 9.8% MoM. However, it rises 25.4% YoY in November. Its gross client acquisition drops 16.6% YoY to 5 lakh during the month. The company appears in a screener of stocks underperforming their industry price change in the quarter.

  • Bansal Wire Industries is falling as it receives a show-cause notice worth Rs 202.8 crore from the GST authority for FY20.

  • Nifty 50 was trading at 26,030.05 (-2.2, 0.0%), BSE Sensex was trading at 85,150.64 (12.4, 0.0%), while the broader Nifty 500 was trading at 23,816.85 (-5.4, 0.0%).

  • Market breadth is in the green. Of the 2,052 stocks traded today, 1,152 were in the positive territory and 832 were negative.

Riding High:

Largecap and midcap gainers today include Biocon Ltd. (410, 2.8%), Wipro Ltd. (254.69, 1.8%) and Hindustan Zinc Ltd. (504.40, 1.8%).

Downers:

Largecap and midcap losers today include Indian Bank (812.80, -5.4%), Punjab National Bank (119.80, -4.4%) and Hitachi Energy India Ltd. (21,850, -4.0%).

Movers and Shakers

26 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Birlasoft Ltd. (422.75, 4.4%), DOMS Industries Ltd. (2,609, 4.2%) and Sonata Software Ltd. (364.45, 4.1%).

Top high volume losers on BSE were Indian Bank (812.80, -5.4%), Angel One Ltd. (2,670.20, -5.1%) and KNR Constructions Ltd. (150.74, -4.9%).

Bombay Burmah Trading Corporation Ltd. (1,882.50, 3.9%) was trading at 43.9 times of weekly average. Hatsun Agro Products Ltd. (1,043.20, 1.3%) and EIH Ltd. (378.70, 0.2%) were trading with volumes 22.5 and 10.2 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

5 stocks hit their 52 week highs, while 25 stocks were underachievers and hit their 52 week lows.

Stocks touching their year highs included - Asian Paints Ltd. (2,953.50, 0.0%), Can Fin Homes Ltd. (890.30, -1.5%) and eClerx Services Ltd. (4,911.40, 2.4%).

Stocks making new 52 weeks lows included - BASF India Ltd. (4,082.60, -0.6%) and Bata India Ltd. (977.45, 1.3%).

9 stocks climbed above their 200 day SMA including Birlasoft Ltd. (422.75, 4.4%) and DOMS Industries Ltd. (2,609, 4.2%). 24 stocks slipped below their 200 SMA including Wockhardt Ltd. (1,415.30, -5.3%) and RHI Magnesita India Ltd. (454.30, -2.5%).

logo
The Baseline
03 Dec 2025
Could Rs 90 per dollar be good for India?
By Swapnil Karkare

Today’s Gen-Z gets triggered easily by events, complaining of “stress” and “anxiety”. But they’ve never known the collective tension India felt in the early 2000s, when Sachin Tendulkar entered the "nervous nineties" while batting. When his score hit that level, he would get jittery. Reaching 100 felt like an impossible crawl.  We would watch the match through our fingers. Every ball was a heartbreak waiting to happen.

That same nervous energy is now in the currency markets.

At the start of the year, one dollar cost Rs 86. Today, it’s hit Rs 90. But unlike cricket where every Indian wanted Sachin to cross 100, the currency market is split. Importers are praying for levels of Rs 85–86. Exporters are hoping for Rs 100. 

In the meantime, the Indian economy looks fantastic. GDP growth surprised on the upside, rising over 8% in the September quarter. Fundamentals are strong, and consumer demand is improving.  The dollar is down 9%. By every traditional metric, this is not a moment when the rupee should be falling.

So what's going on? We dig a bit deeper. 


“It’s just maths,” the RBI says. Really?

A big part of the RBI Governor's job is staying calm, at least outwardly, while everyone else gets stressed. Governor Sanjay Malhotra is good at that.  When asked about the falling rupee by sweaty investors and journos, he gave a clean explanation: "inflation differentials drive long-term currency trends".

If India’s inflation is higher than America’s, the rupee has to depreciate over time to remain competitive. Historically, India’s inflation ran around 4% more than the US, and the rupee depreciated around 5% annually, almost in sync.

Malhotra has downplayed the rupee's depreciation as "just maths" and not a crisis. That’s the long term story. But there’s been a near-term change too, which starts with our central bank.


A big change in the RBI’s playbook

As we wrote earlier this year, the RBI kept the rupee unnaturally stable under former governor Shaktikanta Das. Nothing bounced, nothing swung. It was like “batting on a flat Melbourne pitch,” economist Arvind Subramanian says (a lot of people like cricket metaphors, it's not just me).

Under Das, this approach resulted in a stronger-than-expected rupee.

That has changed under Governor Malhotra, and the RBI is letting the rupee move more freely, stepping in only when volatility spikes. From July onwards for example, the RBI sold $30 billion to prevent a rapid slide after the trade shock and higher US tariffs, per Bloomberg. But over the last few weeks, traders say the RBI is once again hands-off.

The IMF has noticed the shift in policy as well. It has reclassified India’s currency regime from "stabilized" to the more flexible "crawl-like". While this means a weaker rupee in the short run, it is a massive boost to India's credibility. The global market sees a currency that is reflecting real dynamics, not artificial defence.

It also reduces speculation, builds trust, and frees the RBI to focus on domestic issues, while the exchange rate absorbs external shocks.


Enter Donald Trump

Some of the rupee’s pain can be traced back to Washington. President Trump’s reciprocal tariffs hit Indian goods hard. Analysts at the time expected a quick trade deal with the US, and the rupee even strengthened to Rs. 83–84 in May 2025.

Things have reversed since then:

  • By August, most Indian exports faced 50% tariffs

  • In September the US administration announced the H-1B visa fee hike

  • Combine this with $16B in equity outflows and a record $41B trade deficit in October, and the rupee became Asia’s worst performer.

Meanwhile, Taiwan, Korea and Malaysia, all with trade surpluses and lighter tariffs, saw their currencies appreciate.


Is 90 per dollar the new normal?

Many analysts thought that the worst was over for the rupee. Their year-end expectation was Rs 88.5 per dollar. Others, like RBL Bank’s Anitha Rangan, stayed cautious, and have been predictingRs 90–92 as the RBI rebuilds reserves and exports stay weak.

But almost no one expects the rupee to improve beyond Rs 87–88 soon. For now, Rs 90 is the new normal. A Union Bank report added that geopolitics and tariffs will drive the rupee from here. Most experts agree that a US India trade deal is the fastest path to a stronger rupee.


No more photoshop: why a calibrated depreciation may be good for India

Countries like Vietnam, where exports are 90% of GDP, are letting their currencies weaken intentionally. It keeps their goods competitive despite US tariffs. China used the same strategy in 2019, during Donald Trump’s first term.

Vietnamese manufacturers like Pham Xuan Hong, who leads a group of clothing companies in Ho Chi Minh City,say a weaker dong is directly helping them survive higher costs and tariffs. Indian exporters feel similarly, that letting the rupee fall will help offset tariff pressure and protect margins.

Pankaj Chadha of the Engineering Export Promotion Council (EEPC) India says exporters are seeking Rs 103 per dollar — a big number, but the sentiment is not illogical. 

Even JP Morgan’s Sajjid Chinoy  suggests that letting the Indian rupee depreciate may be the smarter move. Besides a more credible exchange rate, a softer rupee lets exporters stay competitive until a trade deal happens. It also blunts China’s advantage — costlier Chinese imports mean that Indian firms are more competitive against Chinese products, and this would also narrow the trade deficit. 

So maybe, we don't need to be that nervous. The central bank has shown a readiness to step in when speculation spikes. The fact is that the rupee no longer has a beauty filter on; we are in a currency regime that reflects reality more clearly.

logo
The Baseline
02 Dec 2025
Five stocks to buy from analysts this week - December 2, 2025
By Ruchir Sankhla

1. KPIT Technologies

ICICI Direct maintains its ‘Buy’ rating on this software firm with a target price of Rs 1,400, an upside of 11.7%. The company reported strong Q2FY26 results, with revenue up 5.8% YoY to Rs 1,611.3 crore, driven by improvements across US, European, and Asian markets. Analysts Bhupendra Tiwary and Anjini Sharma remain positive, citing growth from the Caresoft and N-Dream acquisitions and rising deal wins.

Management attributes revenue growth to improved client sentiment and renewed traction in autonomous, cybersecurity, after-sales diagnostics, and commercial vehicle programs. However, net profit fell 17% to Rs 169.1 crore due to elevated one-time expenses and finance costs from the Caresoft acquisition. Analysts note KPIT's shift from services to end-to-end solutions and greater use of fixed-price contracts will enhance delivery efficiency and profitability.

Tiwary and Sharma foresee strengthening demand from Europe, India, and China, along with a robust deal pipeline, driving medium-term revenue growth. A 3-year, $100 million deal with a European original equipment manufacturer will ramp up from Q3FY26, supporting near-term revenue. Analysts expect KPIT to deliver revenue and net profit CAGR of 12.3% and 15.9% respectively, over FY26-28.

2. Radico Khaitan:

Emkay retains its ‘Buy’ call on this alcohol manufacturer with a target price of Rs 3,700 per share, an upside of 15.2%. Analysts Nitin Gupta and Mohit Dodeja believe the company's strong execution in driving volumes and easing raw material prices will support both top-line and earnings growth.

Management expects to sustain double-digit volume growth, with its prestige and above (P&A) segment growing 15-20%. It sees good execution as crucial for boosting international market volumes, helped by the D'Yavol Spirits BV acquisition, which adds tequila and scotch to Radico’s portfolio. Analysts note that Radico’s market share in Andhra Pradesh jumped to 30% from 10%.

Gupta and Dodeja emphasise that lower grain prices and vertical integration from its extra-neutral alcohol facility will benefit the company's margins. They add that increasing consumer demand, Radico’s diverse product portfolio, and the potential opening of the Bihar market will boost revenue growth. Analysts expect Radico to deliver a revenue CAGR of 17.2% and a net profit CAGR of 38.3% over FY26-28.

3. PB Fintech:

Geojit BNP Paribas upgrades this software company to a ‘Buy’ rating, with a target price of Rs 2,031, an upside of 8.8%. The company posted strong Q2FY26 results: net profit surged 165% YoY, and revenue grew 38%. Total insurance premiums improved 40% and online new protection business jumped 44%, driving revenue growth.

Management has focused on profitable expansion, aiming for Rs 1 lakh crore in premiums by FY30. It expects higher renewal income to boost profitability. Diversification of the Point-of-Sale Person (PoSP) business across motor and non-motor products has helped expand market share. CEO Yashish Dahiya highlights steady profitability in the United Arab Emirates (UAE), supported by cross-border health insurance demand and improved claims management.

Analyst Antu Eapan Thomas notes that lending disbursals almost doubled, though core lending faced some pressure. He anticipates PB Fintech will sustain strong long-term growth that will come from rising renewal income, increasing online protection penetration, a more balanced PoSP business, and continued UAE strength. Thomas also expects the company's expanding market share to support revenue and profit growth through FY30.

4. Privi Speciality Chemicals

Motilal Oswal initiates a ‘Buy’ rating on this chemical manufacturer, with a target price of Rs 3,960, an upside of 25%. Analysts Sumant Kumar and Yash Darak see strong potential, citing the company's solid market position and its ability to meet global demand for aroma chemicals. Privi plans to boost its core production capacity to 66,000 metric tonnes from 48,000 by March 2028.

Management expects the proposed merger with Privi Fine Sciences to enhance its green chemistry portfolio. This merger will add bio-based ingredients like furfural, cyclopentanone, and maltol, used to manufacture fragrances and pharmaceuticals, among other products. The company also anticipates growth from its joint venture with Swiss leader Givaudan, which is building a new plant in Mahad, Maharashtra. This plant will produce complex, high-value molecules under long-term agreements.

Kumar and Darak predict robust growth for Privi, forecasting a 27% revenue CAGR, 34% EBITDA CAGR, and 46% net profit CAGR between FY26-28. They believe expanding capacity and increasing green chemistry product sales will drive profitability. Analysts highlight Privi's move towards high-margin, value-added, green chemistry products, which consistently offer gross margins above 40%.

5. Carysil

Anand Rathi maintains its ‘Buy’ rating on this small-cap household products manufacturer with a target price of Rs 1,265, an upside of 27%. Its Q2FY26 results were strong: revenue grew 16% YoY to Rs 2,400 crore, and net profit soared 62% to Rs 272 crore. Robust demand for quartz sinks, stainless steel sinks, and kitchen appliances boosted this, with key segments maintaining high capacity utilisation.

Carysil's management projects about 15% revenue growth for FY26 and expects an 18-20% EBITDA margin. Strong European orders, consistent global brand demand, and ongoing China +1 sourcing benefits drive this outlook. To meet demand, Carysil is expanding, adding 1 lakh quartz sinks by December 2025, increasing stainless steel sink capacity, and boosting faucet production to 1.5 lakh units by Q2FY27. New partnerships with IKEA and Lowe’s should also drive sales volumes.

Analysts Rishab Bothra and Tania Lalla foresee a 17% revenue CAGR and 25% net profit CAGR for FY26-28, driven by rising demand, scale benefits, premiumisation in India, and online sales. Bothra and Lalla noted Carysil has improved its EBITDA margin to 19.2% through better operating efficiency, lower costs, and higher other income.

Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

(You can find all analyst picks here)

Market closes lower, dragged by weakness in media, metal and chemical stocks
By Trendlyne Analysis

Nifty 50 closed at 26,032.20 (-143.6, -0.6%), BSE Sensex closed at 85,138.27 (-503.6, -0.6%) while the broader Nifty 500 closed at 23,822.25 (-100.2, -0.4%). Market breadth is in the red. Of the 2,585 stocks traded today, 870 were on the uptick, and 1,660 were down.

Indian indices closed lower after falling throughout the day, dragged by weakness in media, metal and chemical stocks. The Indian volatility index, Nifty VIX, fell 3.4% and closed at 11.2 points. Solar panel and cell manufacturer Emmvee Photovoltaic closed 9.4% higher as its Q2FY26 net profit jumped 6.8x YoY to Rs 237.9 crore, helped by inventory destocking.

Nifty Smallcap 100 and Nifty Midcap 100 closed lower. Nifty Realty and Nifty Metal closed in the red. According to Trendlyne’s sector dashboard, Fertilizers emerged as the worst-performing sector of the day, with a fall of 1.3%.

European indices are trading mixed. Major Asian indices closed mixed. US index futures are trading in the green, indicating a positive start to the session. Marvell Technology reportedly nears a deal worth over $5 billion to acquire Celestial AI to boost its AI chip capabilities. Meanwhile, CrowdStrike, Bank of Nova Scotia, GitLab, and Pure Storage are set to report their earnings today.

  • Money flow index (MFI) indicates that stocks like Hero MotoCorp and GMR Airports are in the overbought zone.

  • Axis Direct maintains its 'Buy' rating on Biocon, with a target price of Rs 440 per share. This indicates a potential upside of 10.9%. The brokerage believes that the expansion and new product launches in biosimilars and generics, and a rich product mix, will drive revenue and profit growth. It expects the firm's revenue to grow at a CAGR of 19.8% over FY26-27.

  • GHV Infra Projects receives a Rs 109 crore order from GHV (India) to execute civil, mechanical, electrical, plumbing, and finishing work for buildings in Jamshedpur, Jharkhand.

  • Swiggy is rising as it reportedly plans a qualified institutional placement (QIP) of equity shares worth Rs 10,000 crore.

  • HM Bangur, Chairman of Shree Cements, says demand has improved in recent days following the Bihar state elections and the festive season. He projects FY26 volumes of about 36 metric tonnes and an EBITDA of Rs 1,100–1,200 per tonne. He also highlights a strategic shift, with the company moving from a purely value-focused model to a more balanced value-plus-volume approach.

  • Yes Bank and Union Bank of India rise after NSE announces their inclusion in the Bank Nifty index from December 31. The index will now include 14 stocks, up from the current 12, as part of a major methodology change.

  • Motilal Oswal retains its 'Buy' call on Adani Ports & SEZ, with a target price of Rs 1,770 per share. This indicates a potential upside of 16.9%. The brokerage believes that capacity enhancements at key ports, ongoing infrastructure projects, and global port acquisitions provide visibility for top-line growth. It expects the company's revenue to grow at a CAGR of 14% over FY26-28.

  • Ambuja Cements expands its clinker capacity as it commissions a 4 million tonne per annum (MTPA) brownfield unit in Bhatapara, Chhattisgarh, taking its total capacity to 66 MTPA.

  • Data from the Commerce Ministry shows India’s crude oil imports rose 10.3% YoY to 1.2 billion barrels in April–October, even as the import bill fell 4.3% to $82.9 billion amid lower prices. Analysts expect the trend of higher import volumes but softer values to persist, helped by ample global supply and steady demand. Russia remained India’s largest supplier, though its share eased as refiners diversified ahead of tighter Western sanctions, while US shipments grew the fastest, lifting its share to 6.9%.

  • NRB Bearings enters an agreement to form a 75:25 joint venture (JV) with Italy-based Unitec to manufacture a new range of cylindrical roller bearings (CRBs) for the industrial business.

  • Indian Bank lowers its one-year marginal cost of funds-based lending rate (MCLR) to 8.8% and its up-to-three-month treasury bills-linked lending rates (TBLR) to 5.4%, a reduction of 5 basis points, effective December 3.

  • Emmvee Photovoltaic Power surges as its Q2FY26 net profit jumps 6.8x YoY to Rs 237.9 crore, helped by inventory destocking. Revenue grows 2.8x YoY to Rs 1,149.4 crore, supported by an improvement in the photovoltaic (PV) modules segment. It features in a screener of stocks with improving RoE over the past two years.

  • India’s industrial production grows just 0.4% YoY in October, far below expectations and the weakest reading in 14 months. Nomura notes that labour-intensive, tariff-exposed sectors such as leather, textiles, and food products remain under significant pressure from the steep 50% Trump tariffs, with most categories posting sequential declines. It adds that even the first month of broad GST cuts has provided “little relief.”

  • Bajaj Housing Finance plunges to its 52-week low of Rs 95 per share as its promoter, Bajaj Finance, plans to sell a 2% stake (~16.7 crore shares) to meet the minimum public shareholding (MPS) requirement.

  • Indian Hotels' subsidiary, Roots Corp, acquires 51% stake each in ANK Hotels and Pride Hospitality for Rs 109.3 crore and Rs 81.2 crore, respectively.

  • Insolation Energy's wholly-owned subsidiary, Insolation Green Energy, receives orders worth Rs 516.1 crore from renowned companies to supply solar PV modules.

  • Jefferies maintains a 'Buy' rating on KFIN Technologies with a target price of Rs 1,460. The brokerage notes that the domestic mutual fund business remains the company’s primary growth engine, aided by market share gains from stronger onboarding, improved technology, and greater operational efficiency. It expects international revenue to pick up from Q1FY27 as client monetisation improves, and says management’s positive view on pricing should further support robust MF revenue growth.

  • Force Motors' November wholesales grow 52.9% YoY to 2,883 units, driven by a 59.3% YoY increase in domestic sales. However, exports decline 20.8% YoY to 118 units.

  • NACL Industries' board of directors approves raising Rs 250 crore through a rights issue of equity shares.

  • Tata Communications' subsidiary, Tata Communications (Netherlands) BV, enters an agreement to acquire a 51% stake in Commotion Inc for $25.5 million (~Rs 227 crore).

  • Nuvama initiates coverage on Voltamp Transformers with a 'Buy' rating and a target price of Rs 10,200. The brokerage believes the company is well-placed to benefit from growth in T&D, renewable energy, data centres, and semiconductors. It expects Voltamp to outperform other private-capex-linked peers. Despite softer margins, it projects EPS to grow 13–15% by FY27 and anticipates revenue to rise 18% YoY as capacity expands to 20,000 megavolt-ampere (MVA).

  • Hero MotoCorp's monthly wholesales grow 31% YoY to 6 lakh units in November due to higher motorcycle and scooter sales and domestic business. Exports surge by 69.6% YoY to 33,970 units during the month.

  • Amber Enterprises' subsidiary, IL JIN Electronics (India), acquires an 80% stake in Shogini Technoarts for Rs 506 crore.

  • Afcons Infrastructure is rising as it wins engineering, procurement & construction (EPC) orders worth Rs 884 crore for civil infrastructure works under its marine & industrial businesses.

  • Bharat Dynamics rises after securing orders worth Rs 2,461.6 crore from the Indian Army to supply anti-tank guided missiles (ATGMs) and surface-to-air missiles (SAMs).

  • Nifty 50 was trading at 26,141.50 (-34.3, -0.1%), BSE Sensex was trading at 85,325.51 (-316.4, -0.4%), while the broader Nifty 500 was trading at 23,914.90 (-7.6, 0.0%).

  • Market breadth is in the red. Of the 2,084 stocks traded today, 860 showed gains, and 1,142 showed losses.

Riding High:

Largecap and midcap gainers today include Balkrishna Industries Ltd. (2,445.60, 6.3%), Asian Paints Ltd. (2,954.40, 3.0%) and United Breweries Ltd. (1,720, 2.9%).

Downers:

Largecap and midcap losers today include Bajaj Housing Finance Ltd. (97.02, -7.2%), Indian Bank (859.45, -3.1%) and Bajaj Holdings & Investment Ltd. (11,049, -2.5%).

Volume Shockers

22 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Balkrishna Industries Ltd. (2,445.60, 6.3%), Akzo Nobel India Ltd. (3,482.80, 5.6%) and Birlasoft Ltd. (404.95, 5.1%).

Top high volume losers on BSE were Bajaj Housing Finance Ltd. (97.02, -7.2%), Bajaj Holdings & Investment Ltd. (11,049, -2.5%) and Bikaji Foods International Ltd. (700.65, -2.1%).

Gujarat State Petronet Ltd. (298.45, 2.7%) was trading at 102.4 times of weekly average. C.E. Info Systems Ltd. (1,734.80, 3.6%) and Gujarat Gas Ltd. (403.25, 1.7%) were trading with volumes 12.6 and 11.0 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

15 stocks hit their 52 week highs, while 20 stocks were underachievers and hit their 52 week lows.

Stocks touching their year highs included - Ashok Leyland Ltd. (160, -0.2%), Asian Paints Ltd. (2,954.40, 3.0%) and Bank of Baroda (296.90, 0.5%).

Stocks making new 52 weeks lows included - Bata India Ltd. (964.70, -1.0%) and Chambal Fertilisers & Chemicals Ltd. (438.95, -0.6%).

18 stocks climbed above their 200 day SMA including Akzo Nobel India Ltd. (3,482.80, 5.6%) and Birlasoft Ltd. (404.95, 5.1%). 11 stocks slipped below their 200 SMA including Metro Brands Ltd. (1,125.30, -3.7%) and Chalet Hotels Ltd. (879.95, -1.9%).

Market closes flat, dragged by healthcare and realty sectors
By Trendlyne Analysis

Nifty 50 closed at 26,175.75 (-27.2, -0.1%), BSE Sensex closed at 85,641.90 (-64.8, -0.1%) while the broader Nifty 500 closed at 23,922.45 (-10.8, 0.0%). Market breadth is in the red. Of the 2,609 stocks traded today, 1,054 were gainers and 1,496 were losers.

Indian indices closed flat, dragged by the healthcare and realty sectors. However, the Nifty 50 and Sensex touched their all-time highs in the morning session, driven by Q2FY26 GDP growth surging to a six-quarter high of 8.2%. The Indian volatility index, Nifty VIX, closed flat at 11.6 points. Lenskart Solutions closed 4.7% higher as its Q2FY26 revenue grew 18% YoY, led by improvements in the domestic and international markets.

Nifty Smallcap 100 closed in the green, while Nifty Midcap 100 closed flat, tracking the benchmark index. BSE Auto and Nifty India Digital were among the best-performing indices of the day. According to Trendlyne’s sector dashboard, Diversified Consumer Services emerged as the highest-performing sector of the day, with a rise of 1.5%.

European indices are trading mixed. Major Asian indices closed with varied trends. US index futures are trading lower, signalling a cautious start to the session as investors eye the AI industry profits and bets on a potential Fed rate cut later this month. United Health reportedly sells Banmedica for $1 billion to aid turnaround amid higher medical costs.

  • Relative strength index (RSI) indicates that stocks like GMR Airport and Federal Bank are in the overbought zone.

  • Maruti Suzuki India is rising as its total wholesales jump 26.2% YoY to 2.3 lakh units in November, driven by a 60.9% increase in exports. Total domestic passenger vehicle sales grow 19.7%.

  • Escorts Kubota is rising as its total wholesales grow 17.9% YoY to 10,580 units in November. Exports surge 87.7% to 458 units, while domestic wholesales increase 15.9% to 10,122 units.

  • TVS Motor rises as its total wholesales grow 30% YoY to 5.2 lakh units in November, driven by a 27% YoY increase in two-wheelers and a 58% YoY growth in international business.

  • India’s gross GST collection for November edges up 0.7% YoY to Rs 1.7 lakh crore. Net GST receipts stand at Rs 1.52 lakh crore. Refunds issued during the month declined by 4% to Rs 18,196 crore.

  • Patel Engineering's board of directors approves a rights issue of 14.8 crore shares worth Rs 399 crore at an issue price of Rs 27 per share. The board sets December 4 as the record date for the issue.

  • Lenskart Solutions is rising sharply as its Q2FY26 net profit jumps 19.6% YoY to Rs 102.2 crore. Revenue grows 18% YoY to Rs 2,129.4 crore, led by improvements in the domestic and international markets. It features in a screener of stocks with rising net cash flow and cash from operating activities.

  • Arkade Developers receives approval from the National Company Law Tribunal (NCLT) to demerge its subsidiary, Filmistan, from itself.

  • Mahindra & Mahindra’s total vehicle sales rise 19% YoY to 92,670 units in November. In the utility vehicles segment, the company sells 56,336 units in the domestic market, marking a 22% increase, and 57,598 units overall, including exports. Domestic commercial vehicle sales rise 17%. The strong performance was driven by sustained demand following recent tax cuts.

  • Wockhardt surges more than 10% as the US FDA approves its new drug application (NDA) for Zaynich antibiotic. The antibiotic is used against the gram-negative pathogens, which are responsible for prolonged hospitalisation and high mortality. The US FDA also grants the company fast-track designation for this NDA to address urgent, unmet medical needs.

  • Ashok Leyland is rising as its total sales rise 29% YoY to 18,272 units in November. Its medium and heavy commercial vehicles' sales increase by 27%, while light commercial vehicles' sales grow by 33%.

  • SML Mahindra hits its 5% upper limit as its total sales grow 102% YoY to 1,087 units in November. Passenger vehicle sales increase 116% YoY, while cargo vehicles are up 83%.

  • Tobacco stocks like ITC and Godfrey Phillips decline after Finance Minister Nirmala Sitharaman introduces the Central Excise (Amendment) Bill, 2025, along with the “Health Security se National Security” Cess Bill, outlining the proposed tax structure for cigarettes, tobacco products, and pan masala manufacturing. The government has reportedly proposed excise duty bands for cigarettes based on stick length.

  • Authum Investment & Infrastructure's board of directors approves a bonus issue of shares in the ratio of 4:1.

  • Neuland Laboratories' board of directors approves a capex of Rs 189 crore to set up a research & development (R&D) facility in Hyderabad.

  • Sterling and Wilson Renewable Energy signs a five-year partnership agreement and receives its first purchase order from Adani Green Energy. The Rs 1,381 crore order involves a Balance of System package for three solar projects at the Khavda Renewable Energy Park in Gujarat, covering the supply of goods and onsite services.

  • India’s manufacturing PMI slips to a nine-month low of 56.6 in November, down from 59.2 in October. The slowdown was due to reduced demand following stringent US tariffs. Both factory output and new orders grew at their slowest pace since February, while international demand also weakened.

  • Waaree Energies is rising as it secures an order to supply 140 MW of solar modules.

  • ICICI Bank rises as it receives approval from the Reserve Bank of India (RBI) to acquire a 100% stake in ICICI Prudential Pension Funds Management (ICICI PFM) from ICICI Prudential Life Insurance (ICICI Life).

  • Dalmia Bharat's subsidiary, Dalmia Cement (Bharat), receives a Rs 143.4 crore show-cause notice from the Central GST for AY19.

  • India’s Q2FY26 GDP grew 8.2%, beating economists’ estimates of 7.2% and prompting several upward revisions to full-year growth forecasts. However, economists note that nominal GDP growth of 8.7%, though slightly above expectations, still signals pressure on corporate earnings. They also add that the chances of an RBI rate cut in December now appear slim.

  • Tega Industries rises as it enters an agreement with an affiliate of funds managed by American Industrial Partners (AIP) to acquire Molycop at an enterprise value of $1.5 billion.

  • Brigade Enterprises is rising as it signs a joint development agreement to develop a premium residential project in Begumpet, Hyderabad. The project spans approximately 3 acres, with a gross development value (GDV) of around Rs 800 crore and a total development potential of 0.5 million square feet.

  • NCC is rising as it secures multiple orders worth Rs 530.7 crore in the buildings, water and transportation segments.

  • Maharashtra Seamless is rising as it receives an order worth Rs 217 crore from Oil and Natural Gas Corp (ONGC) to supply seamless pipes used in exploration, drilling and production activities.

  • Nifty 50 was trading at 26,291.05 (88.1, 0.3%), BSE Sensex was trading at 85,983.60 (276.9, 0.3%) while the broader Nifty 500 was trading at 24,019.70 (86.5, 0.4%).

  • Market breadth is ticking up strongly. Of the 2,148 stocks traded today, 1,489 were on the uptick, and 569 were down.

Riding High:

Largecap and midcap gainers today include TVS Motor Company Ltd. (3,661.80, 3.7%), Hindustan Zinc Ltd. (499.85, 3.0%) and Hyundai Motor India Ltd. (2,395.70, 3%).

Downers:

Largecap and midcap losers today include Max Healthcare Institute Ltd. (1,125.40, -3.2%), GlaxoSmithKline Pharmaceuticals Ltd. (2,493, -3.0%) and Page Industries Ltd. (37,405, -2.4%).

Volume Rockets

12 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Wockhardt Ltd. (1,472.20, 19.2%), ZF Commercial Vehicle Control Systems India Ltd. (14,827, 12.3%) and TVS Holdings Ltd. (15,250, 6.4%).

Top high volume losers on BSE were Bata India Ltd. (974, -2.5%) and Star Health and Allied Insurance Company Ltd. (481, -1.4%).

JM Financial Ltd. (154.58, 6.4%) was trading at 15.7 times of weekly average. Indian Energy Exchange Ltd. (146.70, 5.3%) and Sterling and Wilson Renewable Energy Ltd. (229.47, 1.6%) were trading with volumes 5.7 and 4.7 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

25 stocks hit their 52 week highs, while 15 stocks hit their 52 week lows.

Stocks touching their year highs included - Adani Ports & Special Economic Zone Ltd. (1,530.50, 0.9%), AIA Engineering Ltd. (3,840, -0.6%) and Bank of Baroda (295.55, 2.0%).

Stocks making new 52 weeks lows included - Bata India Ltd. (974, -2.5%) and Jyothy Labs Ltd. (295.50, -1.5%).

16 stocks climbed above their 200 day SMA including Wockhardt Ltd. (1,472.20, 19.2%) and JSW Holdings Ltd. (21,125, 4.4%). 12 stocks slipped below their 200 SMA including KPR Mill Ltd. (1,043.10, -3.4%) and Max Healthcare Institute Ltd. (1,125.40, -3.2%).

logo
The Baseline US
30 Nov 2025
The magic weight loss pill that could rewrite the anti-obesity market

We’re right on schedule for post-Thanksgiving regret — when you ask yourself if you really needed to reload your plate with food for the third time. Eating like it’s a competitive sport felt great in the moment. What’s a few pounds when the mashed potatoes and gravy were that good?

But Susan, who’s been on semaglutide for more than six months, had a very different Thanksgiving. The drug’s active ingredient suppressed her hunger, made her feel full. “I stared at a plate of stuffing and didn’t feel the usual urge to dive in,” she said.

That ability — to turn someone away from a delicious dish against all odds — is reshaping the stock market for GLP drug manufacturers. Drug maker Eli Lilly for example, has seen its stock price surgenearly 40% over the past year, and cracked the trillion-dollar club.

But the original pioneer, Novo Nordisk, maker of Ozempic and for a brief time, Europe’s most valuable company, saw its valuation drop by more than 50% last year. It took another hit after its Phase 3 Alzheimer’s trials failed.

The winner in this market is changing fast. Even with the current Lilly–Novo duopoly, the anti-obesity market is getting more competitive, with pricing fights, new formats, and a innovation race that is changing who stays on top.


What’s driving the trillion-dollar rally?

OnNovember 21, 2025, Eli Lilly became the first healthcare company to reach a $1 trillion market cap. Analysts don't see this as a peak — it is just confirmation that Lilly now leads the obesity market, and is going to keep soaring.

Morgan Stanley raised its price target for Lilly by another 10% to $1,290, arguing that the weight-loss drug boom is still in its early innings. With supply bottlenecks easing, Morgan Stanley models show sales continuing to beat expectations.

Bank of America and Truist Securities echo that view, crediting Lilly's massive new investments in manufacturing capacity. Put simply, Lilly can now supply weight loss drugs at a level that competitors can’t match. That advantage is showing up in the numbers.

Lilly's Zepbound Q3 sales nearly tripled to $3.6 billion, overtaking Wegovy’s $3.1 billion, which grew only 18% YoY. Analysts expect Zepbound to pull decisively ahead of Wegovy, with an even bigger lead in 2026.

A big part of the momentum comes from patient experience. Data from drugs.comshows Zepbound outperforming Wegovy across every major category. It delivers higher weight loss with better tolerability: nausea hits 31% of Wegovy users versus 25% of Zepbound users.


The oral revolution

The next battleground is clear: who launches the first, blockbuster weight-loss pill. Pills are cheaper to make, easier to store, and far more convenient than today’s injectable pens, which still face supply shortages.

Analysts expect a big shift from injections to daily pills by the end of the decade. Goldman Sachs has already adjusted its outlook: after factoring in expected price cuts for injectables once pills arrive, it now pegs the global anti-obesity market at $95B by 2030 (down from $130B).

Looking further ahead, Goldman sees a $120B peak by 2033, with $70B coming from the U.S. and $50B from international markets.

At the center of Wall Street’s optimism is Eli Lilly’s pill candidate, Orforglipron. The one-a-day pill has cleared Phase 3 and is expected to launch in 2026. Trials show patients losing around 15% of body weight over 36 weeks.

Its edge lies in chemistry. Unlike fragile, peptide-based injectables, Orforglipron is a small-molecule drug — meaning it can be mass-produced in standard chemical plants, just like statins or Tylenol. If approved, it could ease global supply pressure almost immediately.

The pill is also simpler for users: no fasting windows, no water rules, and you can take it with coffee. Weight loss (10–14.7%) is a touch lower than injectables, but convenience and scalability make it attractive. Side effects are similar to the injection: mild-to-moderate nausea, diarrhea and constipation.

Novo Nordisk’s planned pill is more effective but also higher friction. It's not a new compound, but just high-dose oral semaglutide. It is essentially “Wegovy in pill form” — which delivers 15–17% weight loss but requires an empty stomach, minimal water, and a 30-minute wait before eating to protect the peptide from digestion.

Everyone wants a piece of the pie

As Lilly and Novo plan to launch their pills by 2026, a second wave of biotech challengers is lining up behind them. AMGEN, Viking Therapeutics and Roche are all advancing weight-loss efforts, hoping to break the Lilly-Novo duopoly by 2027.

“Investors clearly prefer Lilly over Novo in the obesity-drug arms race,” said Evan Seigerman of BMO Capital Markets. “But that premium also leaves Lilly exposed to a big downside, if any pipeline drug disappoints.”

By contrast, other companies, which are trading at lower valuations face less downside and more upside if their bets work.

And there's more competition coming. One of the biggest news stories in late 2025 was Pfizer’s re-entry into the obesity space through its acquisition of Metsera. Novo reportedly tried to block the deal with a surprise $9B offer, forcing Pfizer to raise its Metsera bid to $10B.

Why the urgency from Novo? Because Metsera owns what analysts call the industry’s “crown jewel”: MET-097i, a once-monthly GLP-1 injection. Pfizer is betting that if the choice is between 52 injections a year or 12, the winner is obvious.

Analysts say the scramble underscores just how competitive this market is about to get. One put it simply: “As the GLP-1 race widens, companies aren’t just fighting for market share anymore; they’re fighting for staying power.”

As always,

The Trendlyne team

logo
The Baseline
28 Nov 2025
Five Interesting Stocks Today - November 28, 2025
By Trendlyne Analysis

1. Emami:

The stock of this personal products company rose 2.7% on November 27, fueled by a vote of confidence from Goldman Sachs. The global brokerage firm reiterated its ‘Buy’ rating and set an ambitious target price of Rs 825, suggesting the stock could soar by over 60% from current levels.

This optimism comes despite a tough second quarter. Net profit fell 14.8% YoY to Rs 182.3 crore, and revenue dropped 11.5% as sales dipped for key brands like Navratna, Boroplus, and Kesh King. The slump was driven by a “double whammy” of poor timing: delayed stocking of winter products and heavy rains that weakened demand for summer items such as talcum powder.

The company’s Q2 net profit marginally missed Trendlyne's Forecaster estimate by 2.4% as its summer portfolio continued to face pressure amidst excessive rains. Its stock features in a screener of companies where mutual funds have increased shareholding over the past month.

While most categories dipped in Q2, strategic investments grew a solid 16%. October saw a strong turnaround driven by early winter demand. Management now targets double-digit value growth in Q3, further boosted by a lower 5% GST rate on 93% of its portfolio, which is expected to drive volumes in key segments.

Mohan Goenka, the company’s Director and Chairman, is bullish on the third quarter, anticipating high single-digit growth and possibly double-digit growth if winter sales hold up. The company launched 12 new products in the male grooming space, including sunscreens, shower gels, and undereye creams. Looking further ahead, Goenka said: “We believe FY27 will be a stronger year than FY26, as the summer portfolio gains share.”

In their analysis, Goldman Sachs argued that the market has mispriced the stock, claiming that recent earnings volatility is obscuring Emami's solid, underlying growth trajectory. The brokerage expects a strong recovery over the next four quarters but cautioned investors about risks like intense competition, adverse weather conditions, unexpected leadership changes, and overdependence on niche product categories.

2. Inventurus Knowledge Solutions:

Thishealthcare services provider rose 5.8% last week after Nomurainitiated coverage with a ‘Buy’ rating and target price of Rs 2,000. Inventurus Knowledge Solutions (IKS) provides outsourcing and technology solutions to healthcare providers, with nearly 95% of its revenue coming from the US market. Nomura notes that IKS is well-positioned to benefit from prevailing industry trends.

The US healthcare sector is dealing with high costs and regulatory pressures, driving hospitals and insurers to seek partners who can help them streamline operations. The market is projected to grow at around 12% CAGR, reaching Rs 5 lakh crore (~$59 billion) by 2028. Nomura expects demand to be driven by greater adoption of digital systems that connect healthcare providers and improve care coordination.

IKS’ revenue rose 22% YoY inQ2FY26, thanks to increased business from large physician groups and higher demand for billing & collection services. Net profit surged 60%, helped by cost control through AI-enabled automation. The acquisition of AQuity Solutions in October 2023 added a sizable client base, allowing IKS to cross-sell services and lift its EBITDA margin by 530 bps to 34.8%.

CEO Sachin Guptasaid, “We reached the mid-30s in margins earlier than expected, driven by strong growth in our top 10 customers. We’re comfortable with the margin range we are at.” He added that IKS has identified around 50 customers, each with a potential revenue of about Rs 450 crore annually over the next five years.

CFO Nithya Balasubramanian noted that R&D spending has increased to nearly 5% of revenue as the company develops its AI-native platform. She added that IKS currently has a net debt of Rs 412 crore and said excess cash will be used to reduce debt, keeping it on track to be debt-free by FY27.

3. Tilaknagar Industries:

Thisbeverage manufacturer rose 3.2% on November 20 after itlaunched Seven Islands Pure Malt Whisky, marking its entry into the premium segment. The move signals a major shift for the brandy-focused company, which is now establishing whisky as a second major growth engine.

Management says long-term demand trends are fueling the expansion. “With whisky commanding over 60% of India’s spirits market, expanding into this category was the next natural step for us,”explained Amit Dahanukar, Chairman and Managing Director.

On October 8, the company wonapproval from the Competition Commission of India to acquire the Imperial Blue whisky business from Pernod Ricard for Rs 4,150 crore. The deal is set to close in Q3FY26. “The acquisition will be funded through an almost equal combination of equity and debt,” Dahanukarconfirmed.

InQ2FY26, revenue climbed 6.2% YoY, driven by a 16.2% jump in volume and market share gains. However, this growth missed analyst expectations after monsoon disruptions dampened consumption. Higher advertising costs squeezed margins to 15.1% from 17.5%, causing net profit to fall 9.5%.

To strengthen its premium push, Tilaknagar Industriesraised its stake in Spaceman Spirits Lab to 21.3%. The move unlocks access to high-growth craft spirits like Samsara Gin, Sitara Rum, and Amara Vodka, allowing the company to scale them at low cost through its own distribution network. Tilaknagar is alsoexpanding capacity at its Prag Distillery and launching its Mansion House Whisky and Monarch Legacy Edition Brandy in new markets.

Choice International Equities maintains its ‘Buy’ rating and a Rs 650 price target, upgrading its revenue forecasts for FY26 and FY27. The brokerage sees the Imperial Blue deal as a major boost to long-term scale but warns of near-term margin pressure.

4.Voltas:

This consumer electronics maker has risen 1.6% since November 25 after Life Insurance Corp of India (LIC) bought a 2% stake worth Rs 914.9 crore through open market purchases. This move brings LIC's total holding in the company to approximately 7.1%.

Voltas reported a weak set of numbers for the September quarter. The company’s revenue declined 10.4% YoY to Rs 2,347.3 crore, missing Trendlyne’s Forecaster estimates by 2.7%. Net profit fell sharply by 74.4% to Rs 34.3 crore, 63% below estimates.

The company’s cooling products division, which accounts for more than half of its total revenue, saw a 23% decline. The company highlighted that this slowdown was caused by an early monsoon, delayed customer purchases ahead of GST changes, and margin pressures.

In contrast, the electro-mechanical projects segment provided a bright spot, with its revenue rising 10% and its profit nearly doubling during the quarter. The company said this strong performance was driven by steady progress on domestic projects in the electrical, water, and solar sectors.

Voltas retained its market leadership in air conditioners, increasing its market share to 18.5% from 17.8% in the previous quarter. This was helped by new product launches, expanded manufacturing, and a wider sales network. The company aims to further strengthen its position by expanding its premium lineup with 5-star, internet-connected, AI-based models, while still focusing on the popular, high-volume 3-star segment.

Commenting on the company’s performance, Mukundan Menon, Managing Director of Voltas, said, “The second quarter was marked by external challenges, but our fundamentals remain strong. The GST reduction and upcoming new energy efficiency standards will encourage customers who have been waiting to buy in the coming quarters.”

Emkay Global maintains its ‘Buy’ rating on the company with a Rs 1,500 target price. The brokerage believes that despite current challenges, Voltas’ earnings will improve as seasonality normalises in the second half of the year.

5. NBCC (India):

This construction & engineering stock climbed 2.6% on November 20 after landing a Rs 2,966 crore contract from the Nagpur Metropolitan Region Development Authority (NMRDA). This involves developing Phase 1 of the Naveen Nagpur project, an urban development spanning 692 hectares.

The same day, NBCC also sold 609 residential units in Greater Noida through an e-auction, generating Rs 1,069.4 crore. The company won additional orders worth Rs 608.3 crore on November 17 and 24. The largest among these is a project to build an integrated township for the Damodar Valley Corp.

In Q2FY26, NBCC’s revenue jumped 19.5% YoY to Rs 3,017.2 crore, driven by higher execution in its PMC business. Net profit grew 25.7% to Rs 153.5 crore, thanks to lower inventory expenses and write-offs. Increased contributions from ongoing projects, including the completion of phase-1 of the residential development in Netaji Nagar and phase-1 of the Amrapali project, fueled revenue growth. Management expects Phase 2 of the Amrapali project to contribute significantly in the upcoming quarters, with potential sales of Rs 17,000 crore.

Following the results, NBCC’s Chairman & Managing Director, KP Mahadevaswamy, noted, “We are confident of achieving Rs 14,000-15,000 crore in revenue with an EBITDA margin of 6-6.5% during FY26, fueled by completion of projects in the real estate business during H2FY26.”

Elara Capital retains its ‘Buy’ call on NBCC, with a target price of Rs 165 per share, an upside of 41.4%. The brokerage remains positive on the stock due to NBCC’s expertise in redeveloping government land, reviving stalled private realty projects, and buildings & hospitals. It believes the company's asset-light model, stable margins, and lean working capital cycle will drive strong return ratios, exceeding 20%.

Trendlyne’s Forecaster estimates NBCC’s revenue to grow 8.7% to Rs 13,089.4 crore and net profit to jump 33.1% to Rs 720 crore in FY26. While the stock is overvalued based on its current PE, it is undervalued at future earnings estimates.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations